Life sciences investors from Paris-based Andera Partners are seeking €450 million ($530.2 million) for their largest-ever venture fund, as growing maturity in Europe’s biotechnology startup sector draws more investor attention. Andera’s life sciences team began raising BioDiscovery 6 early this year and expects to hold a first closing in the fall and to complete fundraising in 2021, said Olivier Litzka, a partner and health-care investor.

Source: Wall Street Journal August 13, 2020 10:07 UTC